Accelitech: Now Delivering Cancer Treatment at Two-thirds the Speed of Light

CHICAGO, Feb. 22, 2012 /PRNewswire/ -- Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.

Proton therapy is a cutting-edge cancer treatment that targets tumors with a beam of protons traveling at two-thirds the speed of light. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive and highly effective in treating tumors while minimizing damage to surrounding healthy tissue.

Due to the high cost and large scope of developing a proton therapy center, there are only a handful of places in the U.S. where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.

"The technology may be new, but our model for success remains the same," says Kerwin Brandt, President and CEO of Accelitech. "Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale."

About Proton Beam Therapy

Proton Beam Therapy is a type of external radiotherapy that targets tumors with beams of protons. It has fewer side effects than standard radiation and is proven to be effective in sensitive areas such as the head, spine and prostate. Because of the precise localization and unique behavior of protons, higher dosages can be delivered with unrivaled accuracy, sparing more of the healthy tissue that surrounds the tumor. Proton Beam Therapy is a non-invasive, pain-free procedure that offers a reduced risk of secondary cancer incidents, making it an attractive option for the treatment of growing children.

About Accelitech LLC

Accelitech LLC is a leading developer of technology-driven cancer treatment programs nationwide. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States. For additional information about Accelitech and its services, please visit accelitech.biz.

CONTACT: Stacey McClenathan, [email protected]

SOURCE Accelitech LLC